Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al.

Manlio Monti; Paolo Silimbani; Silvia Ruscelli; Giovanni Luca Frassineti

doi:10.1080/14740338.2020.1763301

Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al.

Manlio Monti, Paolo Silimbani, Silvia Ruscelli, Giovanni Luca Frassineti

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1055-1056
Number of pages	2
Journal	Expert Opinion on Drug Safety
Volume	19
Issue number	8
DOIs	https://doi.org/10.1080/14740338.2020.1763301
Publication status	Published - Aug 2020

Access to Document

10.1080/14740338.2020.1763301

Cite this

Monti, M., Silimbani, P., Ruscelli, S., & Frassineti, G. L. (2020). Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al. Expert Opinion on Drug Safety, 19(8), 1055-1056. https://doi.org/10.1080/14740338.2020.1763301

Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al. / Monti, Manlio ; Silimbani, Paolo; Ruscelli, Silvia et al.

In: Expert Opinion on Drug Safety, Vol. 19, No. 8, 08.2020, p. 1055-1056.

Research output: Contribution to journal › Article › peer-review

Monti, M , Silimbani, P, Ruscelli, S & Frassineti, GL 2020, 'Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al.', Expert Opinion on Drug Safety, vol. 19, no. 8, pp. 1055-1056. https://doi.org/10.1080/14740338.2020.1763301

Monti M , Silimbani P, Ruscelli S, Frassineti GL. Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al. Expert Opinion on Drug Safety. 2020 Aug;19(8):1055-1056. https://doi.org/10.1080/14740338.2020.1763301

Monti, Manlio ; Silimbani, Paolo ; Ruscelli, Silvia et al. / Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al. In: Expert Opinion on Drug Safety. 2020 ; Vol. 19, No. 8. pp. 1055-1056.

@article{91cfcf78cd5542a486577ca8103b828f,

title = "Letter to the Editor: Consideration on {"}An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency{"} by Bennett et al.",

author = "Manlio Monti and Paolo Silimbani and Silvia Ruscelli and Frassineti, {Giovanni Luca}",

year = "2020",

month = aug,

doi = "10.1080/14740338.2020.1763301",

language = "English",

volume = "19",

pages = "1055--1056",

journal = "Expert Opinion on Drug Safety",

issn = "1474-0338",

publisher = "Taylor and Francis Ltd.",

number = "8",

}

TY - JOUR

T1 - Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency" by Bennett et al.

AU - Monti, Manlio

AU - Silimbani, Paolo

AU - Ruscelli, Silvia

AU - Frassineti, Giovanni Luca

PY - 2020/8

Y1 - 2020/8

U2 - 10.1080/14740338.2020.1763301

DO - 10.1080/14740338.2020.1763301

M3 - Article

C2 - 32427001

VL - 19

SP - 1055

EP - 1056

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

SN - 1474-0338

IS - 8

ER -